Zobrazeno 1 - 6
of 6
pro vyhledávání: '"L K Fowler"'
Autor:
L K Fowler
Publikováno v:
BMJ. 307:805-805
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6c570168c51ea640351326101c47ad1
https://doi.org/10.1136/bmj.307.6907.805-a
https://doi.org/10.1136/bmj.307.6907.805-a
Autor:
L K Fowler
Publikováno v:
Journal of International Medical Research. 5:297-300
In a one week study of 236 patients, soft gelatine capsules containing 10 mg temazepam (Euhypnos®) were evaluated as a hypnotic in general practice. Doses of 10-30 mg were generally well tolerated and performed satisfactorily in 76% of the patients.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c281d2c3bcb7b4757ad443796adf499b
https://doi.org/10.1177/030006057700500502
https://doi.org/10.1177/030006057700500502
Autor:
L K Fowler
Publikováno v:
The Journal of international medical research. 8(4)
A post-marketing surveillance study of Euhypnos (temazepam), a new short-acting benzodiazepine hypnotic. A total of 12,350 patients requiring a sleep inducer were treated for up to 3 months with doses of 10–30 mg at night. After 2 weeks 80% of Firs
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::92ddf55e541fb0cf67ee36ffdbdea38c
https://pubmed.ncbi.nlm.nih.gov/6105982
https://pubmed.ncbi.nlm.nih.gov/6105982
Autor:
L K Fowler
Publikováno v:
The Journal of international medical research. 5(5)
One hundred and forty-seven patients requiring a hypnotic, took soft gelatine capsules containing 10 mg temazepam (Euhypnos®), 10-30 mg at night, for up to twelve weeks. One hundred and thirty-three patients (90·5%) completed twelve weeks on drug.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ee56366f722e116da194fd0016bd824b
https://pubmed.ncbi.nlm.nih.gov/913856
https://pubmed.ncbi.nlm.nih.gov/913856
Autor:
L K Fowler
Publikováno v:
The Journal of international medical research. 7(5)
An interim report at six months of a post-marketing surveillance study of Euhypnos® Forte, a new high-dose temazepam preparation for the treatment of insomniac patients resistant to conventional hypnotic dosage. The analysis includes 2,043 First Rep
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f4356885fe13b5a8b8de8b085a4d1f8a
https://pubmed.ncbi.nlm.nih.gov/40839
https://pubmed.ncbi.nlm.nih.gov/40839